Green Cross Heparin Sodium Injection
Heparin Sodium
Injections · Prescription medication
Green Cross Corporation
MFDS item code 200302231 · Notified 2003.09.15 · Insurance code 643600851
Prevention and treatment of thrombotic and embolic disorders; diagnosis and treatment of coagulation disorders; inhibition of blood coagulation
This medication is used to prevent thrombosis and treat postoperative thrombosis and pulmonary embolism. It also helps in the prevention and treatment of embolic atrial fibrillation. It is utilized in diagnosing and treating acute and chronic coagulation disorders, and it prevents coagulation during vascular and cardiac surgeries. It prevents cerebral thrombosis caused by cerebral hemorrhage and avoids blood coagulation during transfusion, extracorporeal circulation, and dialysis. It is also effective in treating coronary artery occlusion and peripheral vascular embolism. Overall, it is used to improve blood coagulation issues and prevent and treat related diseases.
Usually, administer by intravenous injection or add to the perfusate during extracorporeal circulation of blood. The effect appears immediately after administration. However, sensitivity to heparin varies widely among individuals; therefore, perform a heparin sensitivity test before administration and determine the maintenance dose by measuring blood coagulation time after administration. Blood coagulation time is usually maintained at 15 ~ 20 minutes or longer after use, but the dose should be determined according to the case, indication, or purpose. 1. Extracorporeal circulation 1) Artificial kidney (1) Systemic heparinization: Before starting dialysis, administer 1,000 ~ 5,000 IU of heparin sodium. After starting dialysis, continuously administer 500 ~ 1,500 IU per hour or intermittently administer an additional 500 ~ 1,500 IU every hour. (2) Regional heparinization: Continuously administer 1,500 ~ 2,500 IU per hour of this drug and neutralize it with protamine sulfate during perfusion in the body. 2) Blood perfusion using a heart-lung machine : Administer 150 ~ 300 IU of this drug per kg of body weight and, as the extracorporeal circulation time is prolonged, add an appropriate amount as needed. After extracorporeal circulation, use protamine sulfate to prevent postoperative bleeding and neutralize the effects of heparin. 2. Intravenous infusion Dissolve 10,000 ~ 30,000 IU of this drug in 1,000 mL of 5 % dextrose injection, normal saline injection, or Ringer's solution and infuse at a rate of approximately 30 drops per minute. When whole blood coagulation time becomes 2 ~ 3 times the pre-administration value, continue infusion at approximately 20 drops per minute. 3. Intermittent intravenous injection Inject 5,000 ~ 10,000 IU of this drug intravenously every 4 ~ 8 hours. Starting 3 hours after initiation of administration, measure whole blood coagulation time every 2 ~ 4 hours and adjust the dose to maintain it at 2 ~ 3 times the pre-administration value. 4. Subcutaneous injection Inject 10,000 ~ 20,000 IU of this drug subcutaneously, followed by a maintenance dose of 15,000 ~ 20,000 IU every 12 hours. Use a different injection site each time to prevent hematoma. 5. Blood transfusion and blood tests For blood transfusion, usually use 400 ~ 500 IU of this drug per 100 mL of blood; for blood tests, use 100 IU per 20 ~ 30 mL of blood.
This medication is very powerful, so it must only be used under the thorough supervision of a doctor. Caution should be exercised when administering to patients with a high risk of bleeding, as bleeding can occur in almost any part of the body following administration. Serious bleeding can occur rarely, so vigilance is necessary. Additionally, this medication contains benzyl alcohol, which can cause life-threatening respiratory problems in premature infants or newborns, so it should not be administered to them. Patients with hypersensitivity to this medication, inappropriate blood coagulation test results, tendencies for bleeding, severe liver or kidney disease, recent surgery or trauma, those who have received spinal and epidural anesthesia, those with a history of specific thrombocytopenia, neonates, and prematures should not use this medication. Patients with consumptive coagulopathy, those with catheters in place, pregnant individuals in the late stages of pregnancy, individuals with severe retinal diseases, liver or kidney dysfunction, elderly individuals, and those with alcohol dependence should use this medication cautiously and have their blood coagulation status monitored regularly. This medication may cause side effects such as bleeding, thrombocytopenia, liver dysfunction, hypersensitivity, skin abnormalities, and osteoporosis with prolonged use, so any abnormal symptoms should be reported to healthcare personnel immediately. Management of bleeding risk should be done through blood coagulation tests, and administration should be discontinued in cases of severe bleeding or thrombocytopenia. If thrombocytopenia occurs, the risk of serious thrombosis is high, so this medication should be stopped immediately, and alternative treatment should be considered. There are many drug interactions with this medication, so the risk of bleeding may increase when used with acetylsalicylic acid, nonsteroidal anti-inflammatory drugs, anticoagulants, etc., so consultation with healthcare personnel is essential. Women who are pregnant or breastfeeding should consult a doctor before using this medication, and particular caution is needed during childbirth due to a high risk of bleeding. Safety in children has not been established sufficiently, and caution should be exercised in the elderly due to a high risk of bleeding. In case of overdose, the risk of bleeding significantly increases, so immediate administration of the antidote protamine sulfate is necessary, and caution regarding side effects is needed even when using the antidote. During treatment, intramuscular injections should be avoided, and mixed injections with antihistamines should not be done.
Hemorrhage, fatal hemorrhage, acute adrenal insufficiency, adrenal hemorrhage, ovarian hemorrhage, retroperitoneal hemorrhage, thrombocytopenia, arterial and venous thrombosis, acute reversible thrombocytopenic purpura, elevated gamma-GTP, elevated LDH, elevated AST, elevated ALT, itching, urticaria, chills, fever, rhinitis, bronchial asthma, tearing, conjunctivitis, cyanosis, tachycardia, feeling of pressure, angioedema, nausea, vomiting, hypotension, dyspnea, bronchospasm, shock, hair loss, vitiligo, hemorrhagic necrosis, hypoaldosteronism, osteoporosis, rebound effect, dyslipidemia, renal function suppression, localized painful hematoma, priapism, diabetes, hyperkalemia, hyperalkalemia, metabolic acidosis, elevated lipase, vascular spasm reaction, erythema, mild pain, ulcer
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container that blocks light, and it is advisable to keep it at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the efficacy of the medication for a longer period.
A colorless or pale yellow transparent liquid in a brown vial.
10 vials/box [(vial (5 milliliters))]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Heparin Sodium
Injections · Prescription medication
Green Cross Corporation
Heparin Sodium
Injections · Prescription medication
JW Pharmaceutical Corporation
Heparin Sodium
Prescription medication
Hallym Pharmaceutical Co., Ltd.
Heparin Sodium
Injections · Prescription medication
JW Pharmaceutical Co., Ltd.
Heparin Sodium
Prescription medication
Huons Co., Ltd.
Heparin Sodium
Prescription medication
Huons Co., Ltd.
Heparin Sodium
Prescription medication
Hyun's Co., Ltd.
Heparin Sodium
Prescription medication
BM Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.